TwinStrand Biosciences
Seattle
About TwinStrand Biosciences
TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $83.5M
- Last round: Series Unknown (Jun 2023)
- Website: twinstrandbio.com
- Phone: 206-202-8946
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/twinstrand-biosciences-57673 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.